Trademark: BTG 1347343
Word
BTG
ID
1347343
Trademark Type
WORD
Status
Protected: Registered/protected
Application Date
05 January 2010
Registration Date
05 January 2010
Renewal Date
05 January 2030
Service
Goods and Services:
Class 1:
Chemicals used in industry, science and medicine; diagnostic reagents and substances all for in vitro use
Chemicals used in industry, science and medicine; diagnostic reagents and substances all for in vitro use
Class 5:
Pharmaceutical and medicinal preparations and substances; veterinary preparations and substances; sanitary preparations for medical purposes; dietetic substances adapted for medical use, vaccines; sera; diagnostic reagents and substances, all for in vivo use; antibodies, therapeutic antibodies for use as anti-lymphocytic agents; pharmaceutical preparations in the form of foams or for use in producing foams; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations; chemical preparations for medical or pharmaceutical purposes; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of immune disorders including type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis
Pharmaceutical and medicinal preparations and substances; veterinary preparations and substances; sanitary preparations for medical purposes; dietetic substances adapted for medical use, vaccines; sera; diagnostic reagents and substances, all for in vivo use; antibodies, therapeutic antibodies for use as anti-lymphocytic agents; pharmaceutical preparations in the form of foams or for use in producing foams; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations; chemical preparations for medical or pharmaceutical purposes; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of immune disorders including type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis
Class 10:
Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, orthopaedic articles; syringes, cannula needles, medical tubing; surgical and medical apparatus for producing and administering foams; surgical and medical apparatus for producing and administering sclerosing foams; surgical or medical apparatus for or for producing foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical devices for assessing the physical characteristics of such foams, devices for intravenous administration of foam and devices for monitoring the position and effect of foam in the human body; diagnostic devices for use in all the above medical conditions; haemofiltration devices
Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, orthopaedic articles; syringes, cannula needles, medical tubing; surgical and medical apparatus for producing and administering foams; surgical and medical apparatus for producing and administering sclerosing foams; surgical or medical apparatus for or for producing foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical devices for assessing the physical characteristics of such foams, devices for intravenous administration of foam and devices for monitoring the position and effect of foam in the human body; diagnostic devices for use in all the above medical conditions; haemofiltration devices